Gastroesophageal Reflux Disease
To view the entire topic, please log in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
- Spectrum of pathology in which gastric reflux causes symptoms and damage to esophageal mucosa
- Reflux esophagitis vs. nonerosive reflux disease
- Prevalence in North America is 18.1–27.8%
Etiology
- Incompetent reflux barrier allowing increase in frequency and duration of gastric contents into esophagus
- Lower esophageal sphincter (LES):
- Main antireflux barrier
- Crural diaphragm attachment (diaphragmatic sphincter)
- Contributes to pressure barrier at gastroesophageal junction
- Esophageal acid clearance via peristalsis and esophageal mucosal resistance are additional barriers
- Most healthy individuals have brief episodes of reflux without symptoms
- Transient lower esophageal sphincter relaxations (TLESRs):
- Occur with higher frequency in gastroesophageal reflux disease (GERD) patients
- Exposed esophageal mucosa becomes acidified and with time necroses
- Decreased LES tone:
- Smoking
- Foods: Alcohol, chocolate, onion, coffee, tea
- Drugs: Calcium channel blockers, morphine, meperidine, barbiturates, theophylline, nitrates
- Delayed gastric emptying, increased body mass, and gastric distention contribute to reflux
- Hiatal hernias associated with GERD:
- Significance varies in any given individual
- Most persons with hiatal hernias do not have clinically evident reflux disease
- Acid secretion is same in those with or without GERD
- Associated medical conditions: Pregnancy, chronic hiccups, cerebral palsy, Down syndrome, autoimmune diseases, diabetes mellitus (DM), hypothyroidism
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
- Spectrum of pathology in which gastric reflux causes symptoms and damage to esophageal mucosa
- Reflux esophagitis vs. nonerosive reflux disease
- Prevalence in North America is 18.1–27.8%
Etiology
- Incompetent reflux barrier allowing increase in frequency and duration of gastric contents into esophagus
- Lower esophageal sphincter (LES):
- Main antireflux barrier
- Crural diaphragm attachment (diaphragmatic sphincter)
- Contributes to pressure barrier at gastroesophageal junction
- Esophageal acid clearance via peristalsis and esophageal mucosal resistance are additional barriers
- Most healthy individuals have brief episodes of reflux without symptoms
- Transient lower esophageal sphincter relaxations (TLESRs):
- Occur with higher frequency in gastroesophageal reflux disease (GERD) patients
- Exposed esophageal mucosa becomes acidified and with time necroses
- Decreased LES tone:
- Smoking
- Foods: Alcohol, chocolate, onion, coffee, tea
- Drugs: Calcium channel blockers, morphine, meperidine, barbiturates, theophylline, nitrates
- Delayed gastric emptying, increased body mass, and gastric distention contribute to reflux
- Hiatal hernias associated with GERD:
- Significance varies in any given individual
- Most persons with hiatal hernias do not have clinically evident reflux disease
- Acid secretion is same in those with or without GERD
- Associated medical conditions: Pregnancy, chronic hiccups, cerebral palsy, Down syndrome, autoimmune diseases, diabetes mellitus (DM), hypothyroidism
There's more to see -- the rest of this topic is available only to subscribers.